Skip to content

THC Farmaceuticals, Inc.: 10-Q filed 2013-05-08

What THC Farmaceuticals, Inc. reported in its quarterly report filed 2013-05-08 (fiscal Q2 2013): 24 published measures, 60 facts as tagged in accession 0001549632-13-000023.

This filing

Form
10-Q (quarterly report)
Filed
2013-05-08
Fiscal period
fiscal Q2 2013
Accession
0001549632-13-000023 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All THC Farmaceuticals, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-03-3149,752USD
At 2012-09-3051,745USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-03-3157,427USD
At 2012-09-3045,226USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-03-31-7,675USD
At 2012-09-306,519USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-01-01 to 2013-03-31-2,619USD90
2012-10-01 to 2013-03-31-14,194USD182
2012-01-01 to 2012-03-31-10,481USD91
2011-10-01 to 2012-03-31-23,779USD183

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-10-01 to 2013-03-31-12,713USD182
2011-10-01 to 2012-03-31-9,700USD183

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2013-01-01 to 2013-03-316,302USD90
2012-10-01 to 2013-03-3112,605USD182
2012-01-01 to 2012-03-318,981USD91
2011-10-01 to 2012-03-3117,363USD183

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-10-01 to 2013-03-3111,333USD182
2011-10-01 to 2012-03-3111,300USD183

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-10-01 to 2013-03-310USD182
2011-10-01 to 2012-03-31-3,800USD183

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2013-03-31-100,518USD
At 2012-09-30-86,324USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-03-3113,133USD
At 2012-09-3013,731USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-03-31-1,594USD90
2012-10-01 to 2013-03-31-12,363USD182
2012-01-01 to 2012-03-31-10,086USD91
2011-10-01 to 2012-03-31-23,285USD183

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-03-312,942USD
At 2012-09-304,337USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-03-314,994USD
At 2012-09-307,624USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2013-03-310USD
At 2012-09-30963USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2013-03-312,013USD
At 2012-09-302,028USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2013-01-01 to 2013-03-317,896USD90
2012-10-01 to 2013-03-3124,968USD182
2012-01-01 to 2012-03-3119,067USD91
2011-10-01 to 2012-03-3140,648USD183

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-03-318,968,000shares
At 2012-09-308,968,000shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-03-3183,875USD
At 2012-09-3083,875USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2013-03-319,021USD
At 2012-09-308,423USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2013-03-3133,677USD
At 2012-09-3033,677USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-01-01 to 2013-03-313,400USD90
2012-10-01 to 2013-03-3115,970USD182
2012-01-01 to 2012-03-314,639USD91
2011-10-01 to 2012-03-3116,867USD183

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2013-01-01 to 2013-03-31296USD90
2012-10-01 to 2013-03-31598USD182
2012-01-01 to 2012-03-31420USD91
2011-10-01 to 2012-03-31824USD183

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2012-10-01 to 2013-03-3115USD182
2011-10-01 to 2012-03-31-904USD183

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2012-10-01 to 2013-03-31-963USD182
2011-10-01 to 2012-03-31-893USD183

Inspect the source

Entity
THC Farmaceuticals, Inc. / CIK 0001508594
Captured
SEC response SHA-256
7d3296ec7f95ca0dd49bdedd74a5a9329475d8e7a1d28d148f2c99d1429f5eeb

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001508594.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))